4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
申请人:Mitsubishi Tanabe Pharma Corporation
公开号:EP1439174B1
公开(公告)日:2012-03-21
Imidazolylpyridine therapeutic agents
申请人:Pfizer Inc.
公开号:US04302464A1
公开(公告)日:1981-11-24
A series of 2-substituted-4-(4-imidazolyl)pyridines and the pharmaceutically acceptable acid addition salts thereof as histamine H.sub.2 -receptor inhibitors for controlling gastric acidity.